Walgreens Boots Alliance (WBA)
(Delayed Data from NSDQ)
$9.08 USD
+0.21 (2.37%)
Updated Oct 8, 2024 04:00 PM ET
After-Market: $9.06 -0.02 (-0.22%) 7:30 PM ET
4-Sell of 5 4
C Value D Growth F Momentum D VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$9.08 USD
+0.21 (2.37%)
Updated Oct 8, 2024 04:00 PM ET
After-Market: $9.06 -0.02 (-0.22%) 7:30 PM ET
4-Sell of 5 4
C Value D Growth F Momentum D VGM
Zacks News
Walgreens' (WBA) AllianceRx Pharmacy Will Now Distribute XDEMVY
by Zacks Equity Research
Walgreens' (WBA) subsidiary, AllianceRx Walgreens Pharmacy, is one of the four specialty pharmacies selected to distribute XDEMVY.
Torrid Holdings (CURV) Reports Q3 Loss, Tops Revenue Estimates
by Zacks Equity Research
Torrid Holdings (CURV) delivered earnings and revenue surprises of 40% and 12.18%, respectively, for the quarter ended October 2023. Do the numbers hold clues to what lies ahead for the stock?
Walgreens Boots Alliance (WBA) Flat As Market Sinks: What You Should Know
by Zacks Equity Research
Walgreens Boots Alliance (WBA) reachead $20.79 at the closing of the latest trading day, reflecting no change compared to its last close.
Walgreens (WBA) Launches Rx Savings Finder Digital Tool
by Zacks Equity Research
Walgreens (WBA) introduces Rx Savings Finder to help patients save on prescription medications.
Walgreens Boots Alliance (WBA) Stock Sinks As Market Gains: Here's Why
by Zacks Equity Research
Walgreens Boots Alliance (WBA) reachead $19.98 at the closing of the latest trading day, reflecting a -0.65% change compared to its last close.
Is Invesco High Yield Equity Dividend Achievers ETF (PEY) a Strong ETF Right Now?
by Zacks Equity Research
Smart Beta ETF report for PEY
Walgreens Boots Alliance (WBA) Stock Dips While Market Gains: Key Facts
by Zacks Equity Research
In the most recent trading session, Walgreens Boots Alliance (WBA) closed at $21.03, indicating a -0.9% shift from the previous trading day.
Walgreens Boots Alliance (WBA) Rises But Trails Market: What Investors Should Know
by Zacks Equity Research
Walgreens Boots Alliance (WBA) concluded the recent trading session at $20.76, signifying a +1.52% move from its prior day's close.
Is Invesco Dow Jones Industrial Average Dividend ETF (DJD) a Strong ETF Right Now?
by Zacks Equity Research
Smart Beta ETF report for DJD
Is Invesco S&P 500 Equal Weight Consumer Staples ETF (RSPS) a Strong ETF Right Now?
by Zacks Equity Research
Smart Beta ETF report for RSPS
Should You Invest in the Invesco S&P 500 Equal Weight Consumer Staples ETF (RSPS)?
by Zacks Equity Research
Sector ETF report for RSPS
Should Invesco Dow Jones Industrial Average Dividend ETF (DJD) Be on Your Investing Radar?
by Zacks Equity Research
Style Box ETF report for DJD
Bear of the Day: Walgreens Boots Alliance (WBA)
by Brian Bolan
Competition heated up and Walgreens got the boot.
Here's What Key Metrics Tell Us About Walgreens (WBA) Q4 Earnings
by Zacks Equity Research
Although the revenue and EPS for Walgreens (WBA) give a sense of how its business performed in the quarter ended August 2023, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
Walgreens Boots (WBA) Q4 Earnings Miss Estimates, Margins Down
by Zacks Equity Research
Walgreens Boots (WBA) Q4 retail revenues are impacted by macroeconomic-driven consumer pressure and lower COVID-19 OTC test kit sales.
CPI Increased More Than Expected
by Zacks Equity Research
CPI Increased More Than Expected
CPI, Jobless Claims Send Pre-Markets Lower
by Mark Vickery
The best news in this entire report comes from core CPI year over year, which arrives in-line with estimates at +4.1%.
Walgreens Boots Alliance (WBA) Lags Q4 Earnings Estimates
by Zacks Equity Research
Walgreens (WBA) delivered earnings and revenue surprises of -1.47% and 2.50%, respectively, for the quarter ended August 2023. Do the numbers hold clues to what lies ahead for the stock?
Markets Mostly Higher on Fed Minutes, Ahead of CPI
by Mark Vickery
Year over year, headline CPI is expected to tick down 10 bps to +3.6% and +4.1% on core, down 20 bps.
Business Optimism Index Falls to Four-Month Low
by Zacks Equity Research
Business Optimism Index Falls to Four-Month Low
Pre-Markets Stay in the Green; Pepsi Beats in Q3
by Mark Vickery
Pre-market indices are slightly positive at this hour -- all but the small-cap Russell 2000.
Walgreens Boots Alliance (WBA) Stock Sinks As Market Gains: Here's Why
by Zacks Equity Research
In the most recent trading session, Walgreens Boots Alliance (WBA) closed at $21.81, indicating a -1.67% shift from the previous trading day.
Earnings Preview: Walgreens Boots Alliance (WBA) Q4 Earnings Expected to Decline
by Zacks Equity Research
Walgreens (WBA) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Bear of the Day: Dollar General (DG)
by Andrew Rocco
Dollar General is not living up to its defensive, safe-haven reputation. Despite its low-cost offerings, margins are shrinking while growth is slowing - a poor combination.
Walgreens Boots Alliance (WBA) Gains As Market Dips: What You Should Know
by Zacks Equity Research
Walgreens Boots Alliance (WBA) closed at $22.55 in the latest trading session, marking a +0.58% move from the prior day.